Therapeutic Targeting of EZH2 and BET BRD4 in Pediatric Rhabdoid TumorsYukitomo Ishi(Northwestern University), Rintaro Hashizume(Children's of Alabama)Molecular Cancer TherapeuticsFebruary 28, 202210.1158/1535-7163.mct-21-0646Cited by 26SaveCiteExport RISWatch citationsRelated PapersInhibition of DNA damage repair by the CDK4/6 inhibitor palbociclib delays irradiated intracranial atypical teratoid rhabdoid tumor and glioblastoma xenograft regrowth|Neuro-Oncology|2016|123